{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:05:47Z","timestamp":1793747147390,"version":"4.6.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.intimp.2023.110061","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T20:23:30Z","timestamp":1679948610000},"page":"110061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The immunomodulatory effects of ethosuximide and sodium butyrate on experimentally induced fibromyalgia: The interaction between IL-4, synaptophysin, and TGF-\u03b21\/NF-\u03baB signaling"],"prefix":"10.1016","volume":"118","author":[{"given":"Maaly A.","family":"Abd Elmaaboud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab A.A.","family":"El-Shaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5101-8011","authenticated-orcid":false,"given":"Ahmed M.","family":"Kabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2023.110061_b0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.rbr.2016.10.004","article-title":"Prevalence of fibromyalgia: literature review update","volume":"57","author":"Marques","year":"2017","journal-title":"Rev. Brasil. Reumatol. (English Edition)"},{"issue":"2","key":"10.1016\/j.intimp.2023.110061_b0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.rdc.2009.05.002","article-title":"Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials)","volume":"35","author":"Choy","year":"2009","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"9","key":"10.1016\/j.intimp.2023.110061_b0015","first-page":"e10276","article-title":"The influence of pro-inflammatory cytokines and genetic variants in the development of fibromyalgia: a traditional review","volume":"12","author":"Peck","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.intimp.2023.110061_b0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.31887\/DCNS.2018.20.1\/whauser","article-title":"Facts and myths pertaining to fibromyalgia","volume":"20","author":"Hauser","year":"2018","journal-title":"Dialogues Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.intimp.2023.110061_b0025","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.3390\/ijms22083891","article-title":"Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update","volume":"22","author":"Siracusa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2023.110061_b0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/ar4402","article-title":"Animal models of fibromyalgia","volume":"15","author":"DeSantana","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2023.110061_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107959","article-title":"Animal models of fibromyalgia: What is the best choice?","volume":"230","author":"Brum","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2023.110061_b0040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.mayocp.2012.02.010","article-title":"FibroCollaborative, A framework for fibromyalgia management for primary care providers","volume":"87","author":"Arnold","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.intimp.2023.110061_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00083","article-title":"Pregabalin as a pain therapeutic: beyond calcium channels","volume":"14","author":"Alles","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2023.110061_b0050","doi-asserted-by":"crossref","unstructured":"R.A. Moore, S. Straube, P.J. Wiffen, S. Derry, H.J. McQuay, Pregabalin for acute and chronic pain in adults, Cochrane Database System. Rev. (3) (2009) CD007076.","DOI":"10.1002\/14651858.CD007076.pub2"},{"issue":"12","key":"10.1016\/j.intimp.2023.110061_b0055","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/bph.13906","article-title":"Recent advances in the development of T-type calcium channel blockers for pain intervention","volume":"175","author":"Snutch","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110061_b0060","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.euroneuro.2019.10.012","article-title":"Ethosuximide improves chronic pain-induced anxiety- and depression-like behaviors","volume":"29","author":"Kerckhove","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110061_b0065","doi-asserted-by":"crossref","first-page":"e015380","DOI":"10.1136\/bmjopen-2016-015380","article-title":"Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial","volume":"7","author":"Kerckhove","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.intimp.2023.110061_b0070","doi-asserted-by":"crossref","first-page":"19603","DOI":"10.1038\/s41598-019-56132-4","article-title":"Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome","volume":"9","author":"Nozu","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.intimp.2023.110061_b0075","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jfma.2013.05.013","article-title":"Attenuation of neuropathic pain by sodium butyrate in an experimental model of chronic constriction injury in rats","volume":"113","author":"Kukkar","year":"2014","journal-title":"J. Formosan Med. Assoc. = Taiwan yi zhi"},{"key":"10.1016\/j.intimp.2023.110061_b0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1744-8069-8-14","article-title":"The expression of spinal methyl-CpG-binding protein 2, DNA methyltransferases and histone deacetylases is modulated in persistent pain states","volume":"8","author":"Tochiki","year":"2012","journal-title":"Mol. Pain"},{"key":"10.1016\/j.intimp.2023.110061_b0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bcp.2019.06.023","article-title":"Kinins and their B1 and B2 receptors are involved in fibromyalgia-like pain symptoms in mice","volume":"168","author":"Brusco","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110061_b0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13041-021-00762-1","article-title":"Ethosuximide inhibits acute histamine- and chloroquine-induced scratching behavior in mice","volume":"14","author":"Gadotti","year":"2021","journal-title":"Mol. Brain"},{"key":"10.1016\/j.intimp.2023.110061_b0095","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3389\/fendo.2018.00630","article-title":"Sodium butyrate ameliorates streptozotocin-induced Type 1 diabetes in mice by inhibiting the HMGB1 expression","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2023.110061_b0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcp.2019.05.012","article-title":"Ameliorative effect of imperatorin in chemically induced fibromyalgia: role of NMDA\/NFkB mediated downstream signaling","volume":"166","author":"Kaur","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110061_b0105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnmol.2017.00284","article-title":"Methods used to evaluate pain behaviors in rodents","volume":"10","author":"Deuis","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2023.110061_b0110","first-page":"e3769","article-title":"The tail suspension test","volume":"59","author":"Can","year":"2012","journal-title":"J. Visual. Exp.: JoVE"},{"key":"10.1016\/j.intimp.2023.110061_b0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.seizure.2017.09.015","article-title":"Behavioral effects of antiepileptic drugs in rats: are the effects on mood and behavior detectable in open-field test?","volume":"52","author":"Zimcikova","year":"2017","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.intimp.2023.110061_b0120","first-page":"FF01-5","article-title":"An experimental study to evaluate the effect of memantine in animal models of anxiety in swiss albino mice","volume":"9","author":"Bagewadi","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110061_b0125","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.pnpbp.2009.11.006","article-title":"The effects of rutin on a passive avoidance test in rats","volume":"34","author":"Nassiri-Asl","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.intimp.2023.110061_b0130","doi-asserted-by":"crossref","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","article-title":"an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples","volume":"9","author":"Varghese","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.intimp.2023.110061_b0135","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1007\/s10620-019-05577-8","article-title":"Coexistence of alterations of gastrointestinal function and mechanical allodynia in the reserpine-induced animal model of fibromyalgia","volume":"64","author":"Uchida","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.intimp.2023.110061_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173870","article-title":"Inhibitors of angiotensin I converting enzyme potentiate fibromyalgia-like pain symptoms via kinin receptors in mice","volume":"895","author":"Brusco","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110061_b0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2478\/intox-2013-0020","article-title":"Determination of motor activity and anxiety-related behaviour in rodents: methodological aspects and role of nitric oxide","volume":"6","author":"Sestakova","year":"2013","journal-title":"Interdiscip. Toxicol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110061_b0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11011-015-9786-6","article-title":"Echinocystic acid reduces reserpine-induced pain\/depression dyad in mice","volume":"31","author":"Li","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.intimp.2023.110061_b0155","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fpsyg.2018.00377","article-title":"Cognitive impairments in fibromyalgia syndrome: associations with positive and negative affect, alexithymia, pain catastrophizing and self-esteem","volume":"9","author":"Galvez-Sanchez","year":"2018","journal-title":"Front. Psychol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110061_b0160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pharmthera.2010.03.002","article-title":"Pharmacotherapy in fibromyalgia (FM)\u2013implications for the underlying pathophysiology","volume":"127","author":"Schmidt-Wilcke","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2023.110061_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105232","article-title":"The challenge of differentiating fibromyalgia from small-fiber neuropathy in clinical practice","volume":"88","author":"Bailly","year":"2021","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.intimp.2023.110061_b0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.imlet.2014.01.009","article-title":"Fibromyalgia and cytokines","volume":"161","author":"Rodriguez-Pinto","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2023.110061_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.666914","article-title":"Fibromyalgia and associated disorders: from pain to chronic suffering, from subjective hypersensitivity to hypersensitivity syndrome","volume":"8","author":"Maugars","year":"2021","journal-title":"Front. Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.110061_b0180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/157015909790031201","article-title":"Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise","volume":"7","author":"Marks","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.intimp.2023.110061_b0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0083-6729(03)01006-9","article-title":"Serotonin and the neuroendocrine regulation of the hypothalamic\u2013pituitary-adrenal axis in health and disease","volume":"66","author":"Hanley","year":"2003","journal-title":"Vitam. Horm."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2023.110061_b0190","first-page":"S11","article-title":"Fibromyalgia\u2013pathways and neurotransmitters","volume":"24","author":"Stahl","year":"2009","journal-title":"Hum. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110061_b0195","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s11682-015-9459-4","article-title":"Differential dopamine function in fibromyalgia","volume":"10","author":"Albrecht","year":"2016","journal-title":"Brain Imaging Behav."},{"issue":"6","key":"10.1016\/j.intimp.2023.110061_b0200","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4103\/1673-5374.250567","article-title":"The hypothalamic-spinal dopaminergic system: a target for pain modulation","volume":"14","author":"Puopolo","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"10","key":"10.1016\/j.intimp.2023.110061_b0205","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1002\/art.24849","article-title":"Elevated insular glutamate in fibromyalgia is associated with experimental pain","volume":"60","author":"Harris","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.intimp.2023.110061_b0210","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1113\/expphysiol.2012.069922","article-title":"The glutamatergic system as a target for neuropathic pain relief","volume":"98","author":"Osikowicz","year":"2013","journal-title":"Exp. Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110061_b0215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2009.03.086","article-title":"Increased glutamate and decreased glycine release in the rostral ventromedial medulla during induction of a pre-clinical model of chronic widespread muscle pain","volume":"457","author":"Radhakrishnan","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2023.110061_b0220","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pain.2005.09.025","article-title":"Excitatory amino acid concentrations increase in the spinal cord dorsal horn after repeated intramuscular injection of acidic saline","volume":"119","author":"Skyba","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.intimp.2023.110061_b0225","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/938576","article-title":"Unique cytokine signature in the plasma of patients with fibromyalgia","volume":"2014","author":"Sturgill","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.intimp.2023.110061_b0230","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1093\/rheumatology\/keab146","article-title":"Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis","volume":"60","author":"O\u2019Mahony","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.intimp.2023.110061_b0235","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","article-title":"NF-kappaB signaling pathways in neurological inflammation: a mini review","volume":"8","author":"Shih","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2023.110061_b0240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/JPR.S71959","article-title":"Fibromyalgia patients have reduced hippocampal volume compared with healthy controls","volume":"8","author":"McCrae","year":"2015","journal-title":"J. Pain Res."},{"issue":"4","key":"10.1016\/j.intimp.2023.110061_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18041549","article-title":"Impact of fibromyalgia in the hippocampal subfields volumes of women-an MRI study","volume":"18","author":"Leon-Llamas","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.intimp.2023.110061_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104586","article-title":"Restored presynaptic synaptophysin and cholinergic inputs contribute to the protective effects of physical running on spatial memory in aged mice","volume":"132","author":"Xu","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2023.110061_b0255","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.bbi.2011.09.013","article-title":"Age-related changes in the hippocampus (loss of synaptophysin and glial-synaptic interaction) are modified by systemic treatment with an NCAM-derived peptide","volume":"26","author":"Ojo","year":"2012","journal-title":"FGL, Brain, Behav, Immunity"},{"issue":"21","key":"10.1016\/j.intimp.2023.110061_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21217877","article-title":"Fibromyalgia: recent advances in diagnosis, classification, pharmacotherapy and alternative remedies","volume":"21","author":"Maffei","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2023.110061_b0265","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1359-6446(05)03662-7","article-title":"Targeting N-type and T-type calcium channels for the treatment of pain","volume":"11","author":"McGivern","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.intimp.2023.110061_b0270","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.trsl.2021.01.002","article-title":"Targeting T-type\/CaV3.2 channels for chronic pain","volume":"234","author":"Cai","year":"2021","journal-title":"Transl. Res.: J. Lab. Clin. Med."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2023.110061_b0275","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejphar.2005.08.017","article-title":"The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil","volume":"521","author":"Barton","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2023.110061_b0280","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejphar.2011.11.026","article-title":"Ethosuximide reduces allodynia and hyperalgesia and potentiates morphine effects in the chronic constriction injury model of neuropathic pain","volume":"674","author":"Hamidi","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110061_b0285","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/ejp.1221","article-title":"Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial","volume":"22","author":"Kerckhove","year":"2018","journal-title":"Eur. J. Pain"},{"issue":"47","key":"10.1016\/j.intimp.2023.110061_b0290","doi-asserted-by":"crossref","first-page":"28540","DOI":"10.1074\/jbc.M115.652586","article-title":"Ethosuximide induces hippocampal neurogenesis and reverses cognitive deficits in an amyloid-beta toxin-induced alzheimer rat model via the phosphatidylinositol 3-kinase (PI3K)\/Akt\/Wnt\/beta-catenin pathway","volume":"290","author":"Tiwari","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2023.110061_b0295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jneuroim.2015.11.011","article-title":"IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients","volume":"290","author":"Mendieta","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110061_b0300","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.gene.2013.04.020","article-title":"Association between fibromyalgia syndrome and polymorphism of the IL-4 gene in a Turkish population","volume":"527","author":"Yigit","year":"2013","journal-title":"Gene"},{"issue":"12","key":"10.1016\/j.intimp.2023.110061_b0305","doi-asserted-by":"crossref","first-page":"e28205","DOI":"10.1371\/journal.pone.0028205","article-title":"IL-4 deficiency is associated with mechanical hypersensitivity in mice","volume":"6","author":"\u00dc\u00e7eyler","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.110061_b0310","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.3389\/fimmu.2019.03009","article-title":"Cytokines in pain: harnessing endogenous anti-inflammatory signaling for improved pain management","volume":"10","author":"Vanderwall","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110061_b0315","doi-asserted-by":"crossref","DOI":"10.1097\/j.pain.0000000000001109","article-title":"Interleukin-4 mediates the analgesia produced by low-intensity exercise in mice with neuropathic pain","volume":"159","author":"Bobinski","year":"2018","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.intimp.2023.110061_b0320","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1590\/s0102-865020180060000003","article-title":"Interleukin-4 protects from chemotherapy-induced peripheral neuropathy in mice modal via the stimulation of IL-4\/STAT6 signaling","volume":"33","author":"Shi","year":"2018","journal-title":"Acta Cirurgica Brasil."},{"issue":"1","key":"10.1016\/j.intimp.2023.110061_b0325","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12035-011-8221-1","article-title":"Transforming growth factor-beta in normal nociceptive processing and pathological pain models","volume":"45","author":"Lantero","year":"2012","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110061_b0330","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbadis.2017.12.022","article-title":"Sustained anti-inflammatory effects of TGF-beta1 on microglia\/macrophages, Biochimica et biophysica acta","volume":"1864","author":"Islam","year":"2018","journal-title":"Mol. Basis Dis."},{"issue":"4","key":"10.1016\/j.intimp.2023.110061_b0335","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bbrc.2010.02.094","article-title":"Smad7 and Smad6 bind to discrete regions of Pellino-1 via their MH2 domains to mediate TGF-beta1-induced negative regulation of IL-1R\/TLR signaling","volume":"393","author":"Lee","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2023.110061_b0340","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1101\/gad.14.2.187","article-title":"A mechanism of suppression of TGF-beta\/SMAD signaling by NF-kappa B\/RelA","volume":"14","author":"Bitzer","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.intimp.2023.110061_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmic.2022.100070","article-title":"The gut microbiome: linking dietary fiber to inflammatory diseases","volume":"14","author":"Zhang","year":"2022","journal-title":"Med. Microecol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110061_b0350","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.tips.2021.08.002","article-title":"Histone post-translational modifications as potential therapeutic targets for pain management","volume":"42","author":"Torres-Perez","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2023.110061_b0355","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.phrs.2015.11.026","article-title":"Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice","volume":"103","author":"Russo","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2023.110061_b0360","doi-asserted-by":"crossref","unstructured":"R.R. Bonomo, T.M. Cook, C.K. Gavini, C.R. White, J.R. Jones, E. Bovo, A.V. Zima, I.A. Brown, L.R. Dugas, E. Zakharian, G. Aubert, F. Alonzo, 3rd, N.A. Calcutt, V. Mansuy-Aubert, Fecal transplantation and butyrate improve neuropathic pain, modify immune cell profile, and gene expression in the PNS of obese mice, Proc. Natl. Acad. Sci. USA 117(42) (2020) 26482\u201326493.","DOI":"10.1073\/pnas.2006065117"},{"key":"10.1016\/j.intimp.2023.110061_b0365","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ebiom.2019.07.031","article-title":"Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia","volume":"46","author":"Clos-Garcia","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2023.110061_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2021.107414","article-title":"Sodium butyrate as a selective cognitive enhancer for weak or impaired memory","volume":"180","author":"Vinarskaya","year":"2021","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.intimp.2023.110061_b0375","article-title":"Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction","volume":"153","author":"Cristiano","year":"2022","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2023.110061_b0380","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2009.04.008","article-title":"Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety","volume":"57","author":"Gundersen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2023.110061_b0385","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuropharm.2014.02.017","article-title":"Possible additional antidepressant-like mechanism of sodium butyrate: targeting the hippocampus","volume":"81","author":"Han","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2023.110061_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112861","article-title":"Butyrate emerges as a crucial effector of Zhi-Zi-Chi decoctions to ameliorate depression via multiple pathways of brain-gut axis","volume":"149","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2023.110061_b0395","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2017.12.004","article-title":"Sodium butyrate abolishes lipopolysaccharide-induced depression-like behaviors and hippocampal microglial activation in mice","volume":"1680","author":"Yamawaki","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2023.110061_b0400","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fncel.2020.00083","article-title":"Pregabalin as a pain therapeutic: beyond calcium channels","volume":"14","author":"Alles","year":"2020","journal-title":"Front. Cell Neurosci."},{"issue":"6","key":"10.1016\/j.intimp.2023.110061_b0405","first-page":"E581","article-title":"Chronic pregabalin treatment ameliorates pain, but not depressive-like behaviors, in a reserpine-induced myalgia model in rats","volume":"23","author":"Gonzalez-Soler","year":"2020","journal-title":"Pain Physician"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692300382X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692300382X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:48:05Z","timestamp":1761587285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692300382X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":81,"alternative-id":["S156757692300382X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110061","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunomodulatory effects of ethosuximide and sodium butyrate on experimentally induced fibromyalgia: The interaction between IL-4, synaptophysin, and TGF-\u03b21\/NF-\u03baB signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110061"}}